"At LMH Health (formerly Lawrence Memorial Hospital), our purpose is to be a partner for lifelong health. LMH Health has a rich history. Founded in 1921, LMH is a 174-bed hospital located in Lawrence, Kansas. Through the years, hospital additions have been built and health care services have expanded—a trend that continues today. LMH continues to be a community-owned, not-for-profit hospital that serves the health care needs of the community regardless of an individual's ability to pay. The hospital is accredited by The Joint Commission. In addition, hospital services are surveyed by a variety of other accrediting agencies."

During the past decade, Lawrence Memorial Hospital conducted 117 clinical trials. In the 10-year time frame, 117 clinical trials started and 205 clinical trials were completed, i.e. on average, 175.2% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 66 clinical trials were completed. i.e. 366.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lawrence Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 158 trials, followed by "SWOG Cancer Research Network" with 78 trials sponsored, "Alliance for Clinical Trials in Oncology" with 65 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "Eastern Cooperative Oncology Group" with 21 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lawrence Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 220 trials as a collaborator, "NRG Oncology" with 22 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator and "NCIC Clinical Trials Group" with 10 trials as a collaborator. Other collaborators include 61 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Lawrence Memorial Hospital" are "Breast Cancer" (32 trials), "Lymphoma" (19 trials), "Lung Cancer" (14 trials), "Colorectal Cancer" (12 trials) and "Leukemia" (11 trials). Many other conditions were trialed in "Lawrence Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Lawrence Memorial Hospital" are "Drug" (301 trials), "Other" (206 trials), "Biological" (151 trials), "Procedure" (78 trials) and "Radiation" (63 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (105 trials), "Quality-of-Life Assessment" (61 trials), "Paclitaxel" (32 trials), "Questionnaire Administration" (32 trials) and "Biospecimen Collection" (30 trials). Other intervention names were less common.

The vast majority of trials in "Lawrence Memorial Hospital" are 306 trials for "All" genders, 67 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Lawrence Memorial Hospital". undefined are not yet recruiting, 40 are recruiting, 137 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 164 completed trials in Lawrence Memorial Hospital, 6 suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Lawrence Memorial Hospital, 26 "Phase 1" clinical trials were conducted, 202 "Phase 2" clinical trials and 154 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".